BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors

Haanen, J. and Mackensen, A. and Koenecke, C. and Alsdorf, W. and Desuki, A. and Wagner-Drouet, E. and Heudobler, D. and Borchmann, P. and Wiegert, E. and Schulz, C. and Rengstl, B. and Preussner, L. and Tuereci, O. and Sahin, U. (2021) BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors. In: ESMO Immuno-Oncology Congres, DEC 08-11, 2021, Virtual.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 17 Jan 2023 11:44
Last Modified: 17 Jan 2023 11:44
URI: https://pred.uni-regensburg.de/id/eprint/47734

Actions (login required)

View Item View Item